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CHAPTER 1: Introduction
1.1: Pre-mRNA splicing is carried out by the spliceosome. Pre-mRNA splicing is the
removal of non-coding sequences (introns) and the ligation of coding sequences
(exons) via two transesterification reactions during the maturation to mRNA [1] (Fig. 1).
During the first transesterification reaction, the 2’-hydroxyl group of the branch site
adenosine attacks the 5’ splice site, and during the second transesterification reaction
the free 3’ hydroxyl group of the 5’ exon attacks the 3’ splice site, ligating the two exons
and releasing the intron as a lariat structure [1]. Pre-mRNA splicing is carried out by a
multi mega-Dalton RNA-protein complex called the spliceosome [1]. Two different types
of spliceosomes coexist in many eukaryotes; the more common U2-dependent
spliceosome, which is the focus of this study, and the less abundant U12-dependent
spliceosome [1]. The U2-dependent spliceosome consists of five snRNAs (U1, U2, U4,
U5 and U6) and more than seventy proteins in yeast and about one-hundred proteins in
humans [1-3].
The structure and composition of the spliceosome change throughout the splicing
reaction, making the spliceosome one of the most complex biological machines [4].
Splicing begins with the recognition of the 5’ splice site and branch site by U1 and U2
snRNAs, respectively, to form the pre-spliceosome (Fig. 2). The tri-snRNP complex,
U4/U6·U5, is then recruited to the pre-spliceosome generating the penta-snRNP
structure called the pre-catalytic spliceosome (complex B). The DExD/H-box family
helicases, Prp28 and Brr2, then cause a large-scale structural rearrangement in the
spliceosome [1]. As a result, the U4/U6 duplex is unwound and the U6 snRNA forms
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base-pair interactions with U2. The U1/5’ splice-site interaction is also disrupted and
replaced with a U6/5’ splice-site interaction, forming the activated spliceosome, (Bact)
[1]. Bact is then converted to the catalytically activated spliceosome (B *) in a reaction
mediated by the protein Prp2 [1]. After the first transesterification reaction, B* forms the
complex C, which performs the second transesterification reaction to ligate the two
exons and release the branched intron (Fig.2). The snRNAs can then be re-used in
another splicing reaction.

Figure 1: Two transesterification reactions occur during splicing [1]. First, the 2’-hydroxyl group of branch
site adenosine (circled in red) attacks the 5’ splice site resulting a free 3’-OH of 5’ exon and a branched
intron attached to the 3’ exon. Second, 3’-OH of the 5’ exon attacks the 3’ exon, ligating the two exons
and removing the lariat intron.

1.2: Only a few components are present at the active site of the spliceosome.
Despite the complexity, only a few components are present in the active site of the
spliceosome [5]. These include U2 and U6 snRNAs, as well as the U5 snRNP protein,
Prp8 [5-7]. In the active spliceosome, U2 and U6 form extensive base pairs with each
other (Fig. 3) and the branch site and the 5’ splice site, respectively. High sequence
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Figure 2: Assembly and the catalysis of the spliceosome. Exons and introns are shown in boxes and
black lines respectively. Circles represent the five snRNAs. The U5 snRNP protein, Prp8, enters the cycle
at complex B and remains attached until the end [8].

Figure 3: Alternative secondary structures adopted by the U2-U6 complex. The three-helix junction
proposed by the Guthrie lab suggests that the invariant AGC triad (red) of U6 form intermolecular base
pairs with U2 (Left) [9], while the four-helix junction proposed by the Butcher lab suggests AGC triad form
intramolecular base pairs extending the U6 ISL (Right) [10].

conservation, structural similarity to the group II intron domain V (DV) [11], and genetic
studies have lead to the proposal that U6 plays a catalytic role in pre-mRNA splicing.
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Group II introns are self-splicing ribozymes that are present in certain bacteria [12],
fungi and plants [13]. Both DV of group II introns and U6 snRNA contain an invariant
AGC triad, GNRA-type loop, and a one- or two-nucleotide bulge in almost identical
locations [5]. In U6 snRNA, the AGC triad is found to be important in both catalytic steps
of splicing [14, 15]. The GNRA-type loop in the group II intron forms a tertiary interaction
to properly position DV in the active site [16]. It is believed that the GNRA-type loop in
the spliceosome is also involved in tertiary interactions to facilitate splicing [5]. Crystal
structure and phosphorothioate substitution studies show that both bulge regions of DV
and U6 ISL (A376-C377 of group II intron and U80 of U6 ISL) bind a metal ion that has
been shown to be important for the catalysis [17-21]. These studies suggest that both
group II introns and the spliceosome may have evolved from a common ancestor, and
hence the spliceosome is a ribozyme [20, 22].
1.3: The U2-U6 complex adopts multiple conformations. The structure adopted by
U2-U6 has been a matter of debate for the past few years. Yeast genetic studies from
the Guthrie lab [9] suggest that the U6 AGC triad forms intermolecular base pairs with
U2, and therefore, the U2-U6 complex adopts a three-helix junction (Fig. 3). On the
other hand, mammalian genetic studies from the Manley lab [23] and early NMR studies
carried out on a shorter construct from the Butcher lab suggest that the invariant AGC
triad forms intramolecular base pairs, adopting a four-helix junction [10] (Fig. 3), while
later NMR studies carried out on a longer U2-U6 construct suggest a three-helix
junction [24].
Previous smFRET studies carried out on a minimal U2-U6 construct from our lab
showed that U2-U6 adopts at least three dynamic conformations with distinct FRET
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states (~0.2, ~0.4 and ~0.6) [25]. The relative populations of the three FRET states
revealed by smFRET are dependent on Mg2+ concentration [25]. With increasing Mg2+
concentration, the low FRET state populations are increased, while with decreasing
Mg2+ concentrations, the high FRET states populations are increased. Furthermore, the
ACAGAGA sequence, AGC triad, and U80 of U6 have been hypothesized to form basetriple interactions that are proposed to stabilize the high FRET state (Fig. 4) [26]. It is
hypothesized that when Mg2+ is bound, U80 is stacked into the helix [24], and therefore
it can no longer participate in the base-triple formation, and hence, there is an increase
in the population of the low FRET state. In contrast, when Mg2+ is not bound, U80 is
flipped out from the U6 ISL, and the high FRET state is favored. According to this
model, when Mg2+ is bound, the distance between the U6 ISL and the ACAGAGA
sequence is increased, which in turn increase the distance between the bound metal ion
and the 5’ splice site. Therefore, it is believed that with a constant supply of Mg2+ in
vivo, protein factors may adjust the relative stability of the U2-U6 dynamic
conformations to achieve efficient splicing [5, 24, 25].
1.4: The spliceosomal protein, Prp8, may play an important role in splicing
catalysis. The idea that the spliceosome is a ribozyme has been challenged with the
identification of the U5 snRNP protein, Prp8, which is one of the largest (2413 and 2335
residues in yeast and human, respectively) [27] and well-conserved proteins found in
the nucleus [28-30]. Of all the spliceosomal proteins, Prp8 is the only protein that
extensively cross-links to the 5’ and 3’ splice sites of the substrate pre-mRNA, U5 and
U6 snRNA [31, 32], indicating a catalytic or structural role of Prp8 in splicing [33].
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Studies have shown that Prp8 has several domains, such as a nuclear-localization
domain (NLS), RNA recognition motif (RRM), Jab1/MPN domain, and an RNase H-like

Figure 4: The proposed U2-U6 folding pathway. (A) Base-triples are proposed to stabilize the high FRET
state. When Mg2+ is bound, the conformation is changed and U2-U6 goes to the low FRET state via an
intermediate. (B) The proposed base-triple interactions between ACAGAGA sequence, AGC triad and
U80 [26].

domain [6, 29, 30]. Within the past few years, three groups have resolved the X-ray
crystal structure of a ~250 amino-acid fragment near the C-terminus of yeast and
human Prp8 [27, 30, 34]. Although there are slight conformational differences between
yeast and human structures, all three groups revealed the presence of an RNase H
domain, which consists of two parts, the N-terminal subdomain with an RNase H fold
and a C-terminal subdomain consisting of five alpha helices [6]. The human RNase H
domain has a characteristic five parallel/antiparallel beta strands buttressed by two
alpha helices [30] (Fig. 5). In addition to the aforementioned features, the crystal
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structures also revealed the presence of an unusual beta finger that is unique to the
RNase H domain of Prp8 [6, 30]. At the junction where the N-terminal RNase H domain
juxtaposes the C-terminal alpha helices, a ~25 Å channel is formed, which is likely a
double-stranded RNA binding pocket [6] (Fig. 5). In fact, cross-linking experiments have
shown that the Prp8 RNase H domain interacts with the 5’ splice site [30].

Figure 5: Human RNase H domain. Left: The ribbon structure of human Prp81769-1990. Alpha helices and
beta sheets are shown in red and yellow respectively. Sequence contains two domains; the N-terminal
RNase H domain and the C-terminal cluster of alpha helices. The β2-β3 represents the beta finger unique
to Prp8 RNase H domain. Right: Space-filling model of the corresponding yeast Prp8 domain showing
possible interaction with the 5’ splice site of pre-mRNA.

RNase H is a metalloenzyme that generally uses two metal ions coordinated by
four conserved carboxylates to specifically cleave RNA that hybridizes to DNA;
however, the RNase H domain of Prp8 has only has two aspartate residues (D1853 and
D1854 in yeast and D1782 and D1781 in human) at the positions corresponding to two
of the four metal-coordinating carboxylates [6, 30]. Moreover, no bound metal ions were
observed in either human or yeast crystal structures [30, 34]; however, D1853A and
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D1854A mutants showed a temperature-sensitive phenotype [30]. Therefore, this
observation, together with the fact that the conserved aspartate residues lie in close
proximity to the 5’ splice site, suggests that pre-mRNA catalysis may be carried out by
two conserved aspartate residues and two metal-coordinating ligands in snRNA, making
the catalytic components of the spliceosome a ribonucleoprotein. Alternatively, it is
hypothesized that Prp8 is capable of bringing the catalytically important RNA
components of the spliceosome together to facilitate the formation of the active-site
conformation [24, 25], hence Prp8 is a protein cofactor for an RNA enzyme [32].

Figure 6: The smFRET experiment setup. U2-U6 is immobilized to a quartz slide via biotin-streptavidin
link. The donor (Cy3) and the acceptor (Cy5) are attached to U6. The U2-U6 conformational changes are
measured based on the change in FRET between the donor and the acceptor.

1.5: Splicing errors are attributed to many diseases. Errors in splicing are correlated
with a number of diseases, including various forms of cancer such as leukemia and
ovarian cancer, neurodegenerative disorders like Parkinson’s disease, and genetic
disorders like cystic fibrosis [35-39]. Therefore, understanding the detailed mechanism
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and dynamics of the molecules involved in splicing is important to understand the
underlying molecular mechanisms of related diseases.
1.6: Sm-FRET can be used to study U2-U6 dynamics. Single-molecule fluorescence
resonance energy transfer (smFRET) is a versatile technique that allows studies of the
dynamics of biological molecules that are otherwise hidden in ensemble-average
experiments [40]. SmFRET involves labeling the molecules with at least two
fluorophores; the donor and the acceptor fluorophores, and only the donor is excited
with an appropriate wavelength laser. During smFRET studies, it is important to reduce
background fluorescence, and for this purpose our lab uses prism-based total internal
reflection fluorescence (TIRF) microscopy. In TIRF, the laser reaches the prism at an
angle greater than the critical angle, at which the incident beam is totally internally
reflected and does not penetrate into the sample [40]. Instead, an evanescent wave is
generated at the slide-solution interface. The evanescent wave only penetrates a few
hundred nanometers (100-300 nm) into the solution, which then excites only the
molecules close to the slide surface, and therefore reduces the background
fluorescence [40].
In our study, a minimal U6 construct is labeled with Cy3 (donor) and Cy5
(acceptor) fluorophores, and the donor is excited with a 532 nm laser (Fig. 6).
Depending on the distance between the donor and the acceptor, some of the donoremitted energy is transferred to the acceptor, due to the fact that the Cy3 emission
spectrum overlaps with the Cy5 absorption spectrum. The efficiency of the energy
transfer is given by
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where R is the distance between donor and acceptor, R 0 is the Förster distance, i.e. the
distance that corresponds to 50% efficient energy transfer.
In our single-molecule FRET experiments, the intensities of the donor and the
acceptor fluorophores are collected through the microscope objective and directed to a
CCD camera in two separate channels. The apparent FRET value is given by

where IA and ID are the intensities of the acceptor and the donor, respectively. The
variation of FRET over time then allows the determination of the relative distances
between the donor and the acceptor, which in turn provides valuable information about
the structural dynamics of individual molecules. FRET can therefore be regarded as a
molecular ruler to study the conformational dynamics within biological systems.
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CHAPTER 2: Materials and methods
2.1: RNA purification and labeling. RNA sequences (Table 1) were purchased from
the Keck Foundation Resource Laboratory at the Yale University School of Medicine
and purified and labeled as described [41, 42]. The 2’-hydroxyl protection groups were
removed as described [41]. The RNAs were purified by denaturing gel electrophoresis
(20% wt/vol polyacrylamide and 8 M urea) and diffusion eluted against elution buffer
(0.5 M NH4OAc and 0.1 mM EDTA) overnight at 4 C, followed by chloroform extraction
and ethanol precipitation. The U6 was labeled with Cy5 (GE Healthcare). The labeled
RNA was precipitated by ethanol precipitation and purified by C8 column reverse-phase
HPLC to remove unlabeled and non-deprotected RNA. RNA concentrations were
measured by UV-Vis absorbance at 260 nm.
Name

Description

Sequence

U6

X = dT with C6 Cy3-AUACAGAGAUGAUCAGCAGUUCCCCXGCAUAAG
amino linker for GAUGAACCGUUUUACAAAGAGAU-Biotin
Cy5 labeling

U6F

X = Fluorescein

XAUACAGAGAUGAUCAGCAGUUCCCCXGCAUAAG
GAUGAACCGUUUUACAAAGAGAU

U6-1

X = dT with C6 Cy5-AUACAGAGAUGAUCAGCAGUUCCCCX
amino linker for
Cy3 labeling

U6-2

X = Δ/G/C/A

AGGAXGAACCGUUUUACAAAGAGAUZ

Z = Biotin
U2

UAUGAUGUGAACUAGAUUCGGUUUUCCGUUUCUCUA

Table 1: RNA sequences used in the study. The symbol Δ denotes U80 deletion.
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2.2:

MALDI-MS

Experiment.

Matrix-assisted

laser

desorption

ionization-mass

spectrometry (MALDI-MS) was carried out for Cy3-U6 sample to confirm the position of
the modified nucleotide and therefore the position of Cy5. The RNA sequence (300
pmol) was RNase T1 digested for 15 minutes to produce smaller fragments. The
molecular weights

of

the

fragments were

calculated

by using the

Mongo

Oligo Mass Calculator v2.06. After RNase T1 digestion, the reaction was quenched in
dry-ice, dried and dissolved in 1 µL water. A saturated MALDI matrix solution was
prepared by mixing 3-hydroxypicolinic acid (HPA) in 50% acetonitrile. The MALDI matrix
(1 µL), 100 mM ammonium citrate (0.5 µL) and RNase T1 digested RNA sample (1 µL)
were mixed on the MALDI plate in the given order. The spot was dried and used in
MALDI experiment. A representative spectrum for Cy3-U6 is shown in Figure 7. The
peak that appears at 2654.716 corresponds to the fragment with the amino-modified
nucleotide used for Cy5 labeling. In addition to the fragment with the modified
nucleotide, most of the other digested fragments were also observed within a
reasonable error (Table 2).

Figure 7: The MALDI result reveals the mass of the fragment that is used for Cy5 labeling. The peak that
appears at 2654.716 is the mass of the fragment containing the modified nucleotide for Cy5 labeling. The
peaks at 1963.249 and 2391.170 are two other resulting fragments after RNase T1 digestion.
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Fragment

Sequence

Expected mass

A1:G6
A7:G8
A9:G11
A12:G16
C17:G19
U20:G26
C27:G32
G33:G33
A34:G36
A37:G41
U42:G51
A52:G53
A54:U59

pAUACAGp
AGp
AUGp
AUCAGp
CAGp
UUCCCCGp
CAUAAGp
Gp
AUGp
AACCGp
UUUUACAAAGp
AGp
AUUUAU

3267.597
692.433
998.602
1632.995
997.617
2654.708
1962.204
363.224
998.602
1632.010
3209.919
692.433
2390.739

Expected mass
(without 3'Phosphate )
3249.579
674.418
980.587
1614.980
979.602
2636.693
1944.189
345.209
980.587
1613.995
3191.904
674.418

Observed
mass
N/O*
693.985
999.348
1633.940
999.348
2654.716
1964.155
N/O*
999.348
1633.940
3211.360
693.985
2391.170

Table 2: The expected and the observed masses from MALDI-MS experiments for the fragments resulted
after RNase T1 digestion. All the masses are observed within a 0.5% error. * Not observed.

2.3: Protein purification. The plasmid pMAL-c2x (containing the amino acid sequence
1806-2413 of Prp8 with maltose binding protein (MBP) fused to the carboxyl terminus of
Prp8 fragment) was obtained from McMillan’s lab at the University of Alberta. The
plasmid was inserted into a BL21 expression vector and expressed the cells at 22 °C to
an optical density of 0.4-0.5, at which point the cells were induced by adding 0.3 µM
IPTG, followed by overnight incubation. The culture was centrifuged, to collect the cell
pellet. The cells were lysed by dissolving the pellet in the lysis buffer (20 mM Tris-Cl pH
8.0, 100 mM KCl, 5 mM BME). The supernatant containing proteins was obtained and
passed through the amylose column. Prp8 binds to the amylose resin via MBP. The
protein was then eluted with the elution buffer (20 mM Tris-Cl pH 8.0, 100 mM KCl, 5
mM BME, 10 mM maltose) and cleaved by the TEV protease to remove MBP. Anionexchange column (Q-column) was used to separate MBP from Prp8. [30]. The SDS gel
containing the purified Prp8 fragment is shown in the figure 8.
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Figure 8: The 8% SDS gel for Prp8 purification. Left: EZ-Run, pre-stained protein ladder. Right: Prp818062413. The size of Prp8 Prp81806-2413 is 69 kDa.

2.4: Gel-shift assays. The two RNAs, U2 (4 µM) and U6 (2 µM), were annealed (50
mM Tris-Cl pH 7.5, 100 mM NaCl, 10 mM MgCl2) by heating at 94 °C for 45 s, followed
by 20 min incubation at room temperature. Prp8 was added and incubated for 30 min to
allow it to interact with the U2-U6 complex. An equal volume of 40% glycerol was added
to the reaction mixture and the samples were run on a native gel (8% acrylamide 40%
w/v) using a 50 mM Tris-acetate pH 7.5, 10 mM magnesium acetate, 100 mM sodium
acetate and 5 mM DTT buffer at 4 °C for 8 h at 100 V. The gel was fluorescence imaged
using a Typhoon imager (GE Healthcare) by exciting the Cy3 donor fluorophore at 532
nm.
2.5: Fluorescence anisotropy experiments. Anisotropy experiments were carried out
using a spectrofluorometer with automated polarizers (Varian, Carry Eclipse). The U6
RNA with 5’ fluorescein (25 nM) and U2 RNA (50 nM) were mixed in a standard buffer
(50 mM Tris-HCl pH 7.5, 100 mM NaCl, and 10 mM MgCl2) and heated at 94 °C for 45 s
and then annealed at room temperature for 20 min. Anisotropy was measured for Prp8
concentration from 0-60 µM. Fluorescein was excited at 490 nm (5 nm bandwidth),
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parallel (Iǁ) and perpendicular ( I ) emission intensities were measured at 520 nm (5 nm
bandwidth). Fluorescence anisotropy (r) is given by



where G is an instrument-dependent correction factor.
2.6: Single-molecule experiments. The experimental setup shown in Figure 6 was
used. Single-molecule FRET (smFRET) experiments were performed as described
below. The U2 (4.0 µM) and U6 (2.0 µM) RNAs were annealed in standard buffer (50
mM Tris-HCl pH 7.5, 100 mM NaCl, and 10 mM MgCl2 in saturating trolox) by heating a
10 µL solution at 94 °C for 45 s and cooling at room temperature for 20 min. The U2-U6
complex was diluted to 25 pM and immobilized onto a streptavidin-coated quartz slide
via biotin to generate a surface density of ~0.1 molecules/µm2. In order to prevent nonspecific protein binding, the quartz slides were treated with polyethylene glycol (PEG)
during slide preparation. The protein was injected along with an oxygen scavenging
system (OSS) (10 nM Protocatechuic acid (PCA) and 2.5 mM Protocatechuate-3,4dioxygenase (PCD) and standard buffer) and the slide was incubated for 30 min. The
donor fluorophore was excited in a home-built total internal reflection microscope with a
532 nm laser (3 mW, Spectra-Physics Excelsior). The donor and the acceptor
emissions were separated using appropriate dichroic mirrors (610DCXR, Chroma) and
detected as two side-by-side images on a back-illuminated electron-multiplied CCD
camera (Andor ixon).
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CHAPTER 3: Results and discussion
Single-molecule experiments with U2 and U6 RNAs (Table 1) confirm previous data,
that the U2-U6 complex adopts at least three FRET states, of which ~0.2 and ~0.4 are
well populated while the ~0.6 state is only transiently populated at 10 mM Mg2+
concentration (Fig. 9). Previous SM data showed that increasing Mg2+ stabilizes the low
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200

0
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FRET

0.8
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20
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Figure 9: U2-U6 dynamics in the absence of Prp8. Left: Intensity (top) and the corresponding FRET
trajectory (bottom) of a single U2-U6 complex showing all three FRET states. Donor and acceptor
intensities are shown in green and red, respectively. Top right: The FRET histogram drawn with more
2+
than one-hundred molecules. At 10 mM Mg 0.4 and 0.2 FRET states are mostly populated while 0.6
FRET state is only transiently populated. Bottom right: U2-U6 construct used in the study.

FRET states, thereby separating the U6 ISL from the ACAGAGA sequence; however, if
the metal ion bound at the position U80 of U6 has a role in catalysis or related function,
one would expect the opposite, i.e., upon Mg2+ binding, U6 ISL comes closer to the
ACAGAGA sequence and therefore increase the high FRET state. Many groups
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therefore suggest that in vivo, proteins may be involved in stabilizing the favorable
conformations important for efficient splicing. Since the RNase H domain of Prp8 protein
interacts with catalytically important snRNAs and the pre-mRNA, we propose that Prp8
may be involved in the high FRET state stabilization. To study the effect of Prp8 on U2U6 conformations, smFRET experiments were carried out in the presence of yeast
Prp81806-2413 expressing both the RNase H and MPN domains.
3.1: Prp81806-2413 binds our U2-U6 complex. Gel-shift assays from the McMillan lab
showed that the RNase H domain of human Prp8 binds to an RNA sequence that forms
a four-helix junction similar to U2, U6 and the 5’ splice site interaction of the
spliceosome [30]. In order to test whether yeast Prp81806-2413 binds our U2-U6 construct,
gel-mobility-shift assays and anisotropy experiments were carried out. Even though the
binding affinity is low (~5% when Prp8 is 70 μM), the gel picture shows clearly that
Prp81806-2413 binds our U2-U6 construct (Fig. 10). Compared to the unbound U2-U6, the
bound U2-U6 complex has high FRET, indicating that Prp8 might be involved in
stabilizing the high FRET state as we had hypothesized. The poor binding in the gel
might result from instability of the U2-U6/ Prp81806-2413 complex in the gel. Therefore
alternative methods were used to measure the binding affinity.
3.2: Fluorescence anisotropy measurements reveal Prp81806-2413 binding to U2-U6
complex. Fluorescence anisotropy can be used to monitor protein-nucleic acid
interaction when one of the components is labeled with a fluorophore [43]. Anisotropy
measurements compare the orientation of fluorophores between absorption and
emission by monitoring emission intensity parallel and perpendicular to excitation. If a
fluorophore attached to the molecule of interest interacts with a large molecule such as
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Figure 10: Prp8 weakly binds U2-U6. Top: Gel-mobility-shift assay with Prp81806-2413 and U2-U6 complex.
Lane 1: U6, Lane 2: U2-U6 complex, Lane 3-11: U2-U6 complex and Prp8 (0.01, 0.1, 1, 5, 10, 20, 40, 60,
70 µM respectively). Bottom: Fitting the anisotropy values against Prp8 concentration to a quadratic
equation gives a KD value of ≥30 µM.

a protein, the rate of fluorophore tumbling decreases, and hence the anisotropy
increases. In our study, we tested the change in anisotropy for a fluorescein-labeled U2U6 complex with increasing Prp8 concentration. Supporting our native gel data, the
results show that the anisotropy is increased with Prp8 concentration (Fig. 10). An
estimated dissociation constant (KD) of ≥30 μM was obtained by fitting the data to the
quadratic equation,

where r0, rmax, RNA0, and KD are the lowest anisotropy value, highest anisotropy value,
RNA concentration, and dissociation constant, respectively. We were not able to reach
saturation in these experiments because we are limited by the concentration of the
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protein stock. Compared to the gel-shift assays, anisotropy experiments reveal more
Prp8 binding to U2-U6, supporting the idea that the U2-U6/Prp8 interaction is not stable
during gel-shift assays.
3.3: Single-molecule studies reveal Prp81806-2413 stabilizes the high FRET states.
Supporting our hypothesis, that Prp81806-2413 is involved in stabilizing the high FRET
conformation, we observed a higher percentage of static and dynamic molecules at ≥0.6
FRET state (Fig. 11). Interestingly with increasing Prp8 concentrations, molecules with
FRET states ~0.8 and ~1.0 were also observed (Fig. 10). Three FRET histograms

Figure 11: Characteristic molecules at ≥0.6 FRET states at 10 mM Prp8 concentration. Top left: static
molecules at 0.6 FRET state, top right: fast dynamics between ~0.6 and ~0.2 FRET states, bottom left:
dynamics between ~0.4 and ≥0.6 FRET states, bottom right: dynamics between ~0.4 and ~1.0 FRET
states.

drawn from the smFRET experiments in the presence of Prp8 (0.001, 1 and 20 µM) are
shown in Figure 12. From the histograms, it is clear that Prp8 increases the high FRET
population compared to the low and intermediate FRET states. The fraction of ≥0.6
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Figure 12: Prp8 stabilizes the high FRET states of U2-U6. Left: Higher Prp8 concentrations result a broad
peak that extends from FRET 0.6-1.0. This may be because Prp8 brings the U6 ISL close to the
ACAGAGA sequence and therefore Cy3 and Cy5 come very close together and most of the energy is
transferred from the donor to the acceptor. The broad peak may result due to the fast dynamics at high
Prp8 concentration. Top right: Fitting the fraction of molecules with ≥0.6 FRET state against Prp8
concentration to a modified Hill equation gives a KD value of ≥10 µM. Bottom right: Control SM experiment
with PTB at 20 µM concentration.

FRET states was calculated by integrating the histograms and values were plotted
against Prp8 concentration (Fig. 12). Although we do not reach saturation, it is clear
that with increasing Prp8 concentration, the ≥0.6 FRET state is increased. A
dissociation constant of ≥10 µM was estimated by fitting the data to a modified Hill
equation,

f ( x)  f 0  ( f max  f 0 )(

x^ n
)
K D ^ n  x^ n

where f0, fmax, n, X and KD are the initial fraction of molecules with ≥0.6 FRET state, the
final fraction of molecules with ≥0.6 FRET state, the Hill coefficient, Prp8 concentration,
and the dissociation constant, respectively. The estimated KD is comparable with a
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dissociation constant from a previous study for a closely related Prp8 domain and RNA
sequence [30]. In order to test the specificity of Prp8 in stabilizing the high FRET states,
a control experiment was carried out with the protein PTB (Polypyrimidine Tract
Binding) at 20 µM concentration. The corresponding histogram shows (Fig. 12) that the
high FRET states were not increased with PTB indicating that Prp8 specifically
increases the high FRET states of U2-U6 complex.

Figure 13: Experiments with U6 which are mutated/deleted at the position U80 in the presence of Prp8.
The high FRET states are considerably rescued when the U80 is replaced to a different nucleotide than
when it is deleted.

3.4: Prp8 stabilizes the high FRET states of the U80 mutants. Previous studies from
our lab showed that the U2-U6 complex forms three base-triple interactions (G86C61·U80, U87-G60·G52 and U88-A59·A53) that are important in the stabilization of the
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high FRET state [25] (Fig. 4). In order to investigate the contribution of these base
triples and Prp8, separately on the stabilization of the high FRET state, single-molecule
experiments were carried out using U80 mutated U6 sequences in the presence and
absence of Prp8 (20 µM) (Fig. 13). A three-piece U2-U6 constructs were used in the
study (The GCAUA penta-loop was deleted from the minimal U6 in Figure 8 and
therefore U6 comes in two pieces).
The high FRET stabilization is more apparent when U80 is replaced with G/C/A
than when it is deleted. This may indicate that the high FRET states stabilization by
Prp8 mainly depends on the presence of a nucleotide rather than its identity at the U80
position. Our results show that Prp8 considerably stabilizes high FRET states of U80G.
However, previous studies have shown that U80G has a lethal phenotype [21].
Therefore we hypothesized that not only the high FRET conformation, but also the
identity of the nucleotide is important for the splicing activity. These nucleotides might
have crucial functions such as metal ion binding and/or structural effect.
In summary, the RNase H domain of Prp8 interacts with the minimal U2-U6
construct weakly and it is involved in stabilizing the high FRET state. Furthermore, in
addition to the ~0.6 high FRET state that is observed at 10 mM MgCl 2 in a protein-free
environment, at high Prp8 concentration, a broad band that extends from FRET 0.6-1.0
was reported (Fig. 12). This may due to the fact that Prp8 brings the U6 ISL close in
proximity to the ACAGAGA sequence and AGC triad (Fig. 14) and therefore most of the
energy is transferred from the donor to the acceptor.
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2+

Figure 14: The proposed model for Prp8 in the vicinity of U2-U6. In the presence of Mg , U2-U6 favors
the low FRET states and therefore the high FRET states and transiently populated. However, in the
presence of Prp8, at the same Mg+ concentrations, the high FRET states are dominated.
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CONCLUSIONS
We have carried out sm-FRET experiments to study the effect of Prp8 on the
conformational dynamics of a minimal U2-U6 construct. In the absence of Prp8, low and
intermediate U2-U6 FRET states are more populated while the high FRET states are
only transiently sampled. In the presence of Prp8, however, the high FRET states are
dominant. A broad band that extends from 0.4-1.0 results at high Prp8 concentration,
possibly because Prp8 transiently interacts and partially unwinds helix III resulting in
faster dynamics. Moreover, the results with the U6 mutants show that Prp8 can at least
partially rescue the high FRET states of U80A, U80G and U80C, while it has only a
minimal effect on U80Δ. Therefore, we suggest that the presence of a nucleotide, rather
than its identity is important in stabilizing the high FRET states by Prp8 and hence the
action of Prp8 is robust. As U80G is lethal [21], we suggest that in addition to the high
FRET states, the identity of the nucleotide is important for the activity. Overall, based on
our results we propose a model for the action of the RNase H domain of Prp8 in the
vicinity of U2-U6 (Fig. 14). The increase in time spent in the high FRET states in the
presence of Prp8 suggests that Prp8 may assist in bringing the U6 ISL in close proximity
to the U6 ACAGAGA sequence, and therefore, placing the catalytically important metal
ion at U80 close to the 5’ splice site.
Overall, results in this study enable us to understand the dynamics of the U2-U6
complex at the catalytic center of the spliceosome. The study is exciting as the results
from this thesis may lead towards the discovery of novel therapeutics to cure human
diseases that arise from splicing errors.
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CHAPTER 4: Future directions
Our data suggest that Prp8 stabilizes the U2-U6 high FRET conformations. In
order to further investigate the role of Prp8 in modulating the U2-U6 conformations, we
propose to perform smFRET experiments using mutant Prp8 and U2-U6. The betafinger of the RNase H of Prp8 contains both the first- and second- step alleles [33]. It is
hypothesized that the first-step complex is stabilized by the first-step alleles, while it is
destabilized by the second-step alleles [33]. We propose to carry out smFRET
experiments with the first- and second-step alleles of Prp8 (Fig. 15) to study their
effects on U2-U6 dynamics. We expect to observe different U2-U6 dynamics for
different alleles, in particular, more high FRET state for the first-step alleles than for the
second-step alleles.

Figure 15: The first- (V1860D and T1865K) and second-step (H1863E and V1870N) alleles of Prp8.
Shown in purple are D1853 and D1854 which form an incomplete active site.

The D1854 is one of the aspartate residues that form an incomplete active site of
the RNase H domain of Prp8 and the D1854A mutation has a temperature sensitive
phenotype (Fig. 15). We propose to perform single-molecule experiments with Prp8D1854A to test the effect of the mutation on U2-U6 dynamics. With the mutant Prp8, we
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expect to observe U2-U6 dynamics that are different from the U2-U6 dynamics in the
presence of the wild-type Prp8.

Figure 16: The proposed mutants for U2-U6. Left: The minimal U6 showing the mutations at U80 and
G52. Left: The six-fold U6 mutant that favors the formation of four-helix junction and the A91G mutation of
U6 that favors the formation of the three-helix junction.

We propose to carry out smFRET experiments with a G52C U6 mutant that
disrupts the U87-G60·G52 base triple (Fig. 16). In the absence of Prp8, the G52C
mutation eliminates the high FRET state. It is also important to note that G52 is
protected from RNase T1 and RNase A digestion in the presence of saturating
concentration of the RNase H domain of human Prp8, indicating that Prp8 interacts with
G52 [30].
A six-fold mutant (Fig. 16) of U6 that prevents the formation of helix IB while
maintaining the stability of the U6 ISL has previously shown that molecules mostly exist
in the ~0.4 FRET state and occasionally go to the ~0.6 FRET state [25]. On the other
hand, the U6 A91G mutation (Fig. 16) favors the formation of helix IB by extending helix
II and thereby stabilizing it relative to the U2 stem I [25]. Therefore, this six-fold mutant
U6 (the last three base pairs of the extended U6 ISL are swapped) and A91G U6 will be
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used in our study to test the ability of Prp8 to increase the high FRET population when
the U2-U6 complex preferentially exists either in the ~0.2 or ~0.4 FRET state.
We will also use the RNase H domain of human Prp8 to study the effect of the
protein on the human U2-U6 complex, and hence, compare the effects of the RNase H
domain of human and yeast Prp8 on the U2-U6 dynamics. Altogether the results from
this study will explain the role of RNase H domain of both human and yeast Prp8 in
stabilizing U2-U6 conformations during splicing catalysis.
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ABSTRACT
THE SPLICEOSOMAL PROTEIN PRP8 STABILIZES A COMPACT CONFORMATION
OF THE U2-U6 COMPLEX
by
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Degree: Master of Science
The spliceosome is a large, RNA-protein complex that catalyzes pre-mRNA
splicing during mRNA maturation. The RNA components (small nuclear RNA; snRNAs)
of the spliceosome have been well studied and are believed to be involved in the
splicing catalysis. Although proteins are essential for splicing, they may not be directly
involved in catalysis. Among hundreds of proteins, Prp8 is the only protein that interacts
with all of the catalytically important snRNAs. Therefore, it is hypothesized that Prp8
may catalyze splicing either by directly participating in catalysis or by stabilizing the
conformation of the catalytically active spliceosome. In order to test whether or not Prp8
stabilizes the active-site conformation, we carried out single-molecule fluorescence
resonance energy transfer (smFRET) experiments with catalytically important snRNAs
U2 and U6 and Prp8. We observed that in the presence of Prp8, the population of the
high FRET conformation of U2-U6 that is thought to be the active conformation
increased indicating that one of the functions of Prp8 would be to stabilize the active site
conformation of the spliceosome.
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